Tags : TAK-079

Pharma

Lupus Therapeutics Signs a Research Agreement with Takeda for its

Shots: Lupus Therapeutics (subsidiary of Lupus Research Alliance) collaborates with Takeda to evaluate TAK-079 (NCT03724916) in P-I clinical study assessing TAK-079 vs PBO in 24 patients with moderate to severe systemic lupus erythematosus (SLE) The P-I study evaluates Takeda’s TAK-079 safety, efficacy, PK/PD and will conduct in 20 research centers including member of Lupus Therapeutics’ […]Read More